Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:4 Issue:5 Number:11 ISSN#:2563-5476
RCT
ACE Report #8938
Ace Report Cover Metabolic Disorders

WCO-IOF 2016: Alfacalcidol (Vit D analogue) vs. cholecalciferol (Vit D) for osteoporosis


Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

The effect of alfacalcidol and plain vitamin D on osteoporosis: a randomized controlled trial

Contributing Authors: BP Shrestha J Kathabania

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

80 patients with osteoporosis were randomized to receive either alfacalcidol, a vitamin D analogue, or plain vitamin D (cholecalciferol). Both treatment groups also received calcium supplementation and alendronate. The purpose of this study was to compare the effects on bone mineral density and T-score between alfacalcidol and cholecalciferol. Results demonstrated no significant differences betwee...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.